Catalyst Wire Dossier Catalyst Wire Dossier

VAX2012Q

quadrivalent influenza vaccine · VaxInnate Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VAX2012Q, covering 2015-06-26 to 2015-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years [Phase 2]

See pricing